$TLRY Tilray and other Canadian marijuana companies go PARABOLIC if the US federal government removes cannabis from the Schedule I drug list. If that happens, Tilray stock will skyrocket. A 2-stage DCF model that sets revenues at $7 billion by 2029 and 40% EBITDA margins puts fair value at over $95, a 1,040% upside.
Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.